表紙
市場調查報告書

全球癌症組織診斷市場:各檢驗的種類(免疫組織化學檢驗、 In Situ雜合反應檢驗)、地區:全球市場分析及至2027年的預測

Cancer Tissue Diagnostics Market to 2027 - Global Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Geography

出版商 The Insight Partners 商品編碼 907407
出版日期 內容資訊 英文 159 Pages
訂單完成後即時交付
價格
Back to Top
全球癌症組織診斷市場:各檢驗的種類(免疫組織化學檢驗、 In Situ雜合反應檢驗)、地區:全球市場分析及至2027年的預測 Cancer Tissue Diagnostics Market to 2027 - Global Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Geography
出版日期: 2019年07月12日內容資訊: 英文 159 Pages
簡介

全球癌症組織診斷市場在2018年估算為20億2,541萬美金。該市場在2019年∼2027年間預測將以6.2%的年複合成長率成長,2027年達到34億1,961萬美元的規模。

本報告提供全球癌症組織診斷市場的相關調查,市場機會和趨勢,成長及阻礙因素,各檢驗的種類、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查範圍
  • The Insight Partners調查報告指南
  • 市場區隔

第2章 注意點

第3章 調查方法

  • 覆蓋率
  • 二次調查
  • 一次調查

第4章 市場情況

  • 概要
  • PEST分析

第5章 主要企業的動態

  • 主要市場成長要素
  • 主要阻礙市場因素
  • 主要市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 收益預測及分析
  • 各地區:預測及分析
  • 主要企業的成果

第7章 市場分析:檢驗的各類型

  • 概要
  • 全球市場:2018年及2027年(%)
  • 免疫組織化學檢驗市場
  • In Situ 雜合反應檢驗

第8章 市場分析:各地區

  • 北美:收益及至2027年的預測
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 中南美

第9章 競爭情形

  • 概要
  • 癌症組織診斷市場成長策略:2016年∼2019年
  • 內部成長策略
  • 癌症組織診斷市場內部成長策略:2016年∼2019年 (%)
  • 無機成長策略
  • 癌症組織診斷市場上無機成長策略:2016年∼2019年(%)

第10章 主要企業簡介

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Enzo Biochem Inc.
  • Agilent Technologies, Inc.
  • Cancer Genetics Inc.
  • Merck Kgaa (Sigma-Aldrich)
  • Abcam Plc.
  • Danaher

第11章 附錄

  • The Insight Partners
  • 詞彙表
目錄
Product Code: TIPRE00005672

The global cancer tissue diagnostics market is expected to reach US$ 3,419.61 Mn in 2027 from US$ 2,025.41 in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027.

The market for cancer tissue diagnostics is expected to grow, owing to factors such as growing cancer prevalence across the globe, new product launches & FDA approvals and growing investments for tissue diagnostics are boosting the market over the years. In addition, the emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years. However, factors such as high cost of cancer diagnostics are likely to have a negative impact on the growth of the market in the coming years.

Cancer tissue diagnostic techniques are used to detect the tumor in the malignant tissues. In the last few years, immunohistochemistry (IHC) was used to increase the detection of specific antigens in the tumor tissue. The screening with the help of nonfluorescent chromogens is analyzed with conventional microscopy. There are recent techniques developed for cancer tissue diagnosis. Fluorescence in situ hybridization, the method is used for examination of a specific genetic abnormality in the genome. The hybridized deoxyribonucleic acid (DNA) is examined with particular probes.

The high cost of cancer diagnostics may restrain the growth of the market during the forecast period. Factors such as high costs involved in diagnosis as well as treatment have a restraining effect on the cancer tissue diagnostic market. Cancer diagnostics tests have become so pricey that ordinary people are unable to afford it. High out-of-pocket costs are barriers to potentially life-saving diagnosis or life-prolonging treatments. These sums up to high diagnosis cost, and thus, patients delay or avoid the diagnosis, which results as a barrier to treatment. According to the study by Marten group, the average out-of-pocket cost of a diagnostic mammogram can be $234 on average, while a breast MRI can cost patients $1,021 on average. Therefore, market players need to focus on developing new products that more cost-efficient than the existing ones in the market to gain potential growth.

Global cancer tissue diagnostics market is segmented by test type. On the basis of test type, the market is segmented into immunohistochemical tests and in situ hybridization tests. On the basis of type, immunohistochemical tests are further sub-segmented into breast cancer, colorectal cancer, prostate cancer, stomach cancer, and others. On the basis of type, in situ hybridization tests is further sub-segmented into breast cancer, lung cancer, bladder cancer, and others. In 2018, the breast cancer segment held the largest share in the market, by immunohistochemical tests.

Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, Public Health Agency of Canada, International Agency for Research on Cancer, Canadian Breast Cancer Foundation, National Cancer Institute (NCI), National Institute of Cancer Prevention and Research (NICPR), Pancreatic Cancer Network South Africa, and others.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cancer Tissue Diagnostics Market - By Test Type
    • 1.3.2 Global Cancer Tissue Diagnostics Market - By Geography

2. Global Cancer Tissue Diagnostics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cancer Tissue Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis

5. Global Cancer Tissue Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Growing Cancer Prevalence Across The Globe
    • 5.1.2 New Product Launches & FDA Approvals
    • 5.1.3 Growing Investments For Tissue Diagnostics
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost Of Cancer Diagnostics
  • 5.3 Key Market Opportunities
    • 5.3.1 Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Inclination Towards Personalized Medicine
  • 5.5 Impact Analysis

6. Cancer Tissue Diagnostics Market - Global Analysis

  • 6.1 Global Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis
  • 6.2 Global Cancer Tissue Diagnostics Market, By Geography - Forecasts And Analysis
  • 6.3 Performance of Key Players

7. Global Cancer Tissue Diagnostics Market Analysis- by Test Type

  • 7.1 Overview
  • 7.2 Global Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)
  • 7.3 Immunohistochemical Tests Market
    • 7.3.1 Overview
    • 7.3.2 Global Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.3 Breast Cancer Market
      • 7.3.3.1 Overview
      • 7.3.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.4 Colorectal Cancer Market
      • 7.3.4.1 Overview
      • 7.3.4.2 Global Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.5 Prostate Cancer Market
      • 7.3.5.1 Overview
      • 7.3.5.2 Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.6 Stomach Cancer Market
      • 7.3.6.1 Overview
      • 7.3.6.2 Global Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.7 Others Market
      • 7.3.7.1 Overview
      • 7.3.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 In Situ Hybridization Tests Market
    • 7.4.1 Overview
    • 7.4.2 Global In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.3 Breast Cancer Market
      • 7.4.3.1 Overview
      • 7.4.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.4 Lung Cancer Market
      • 7.4.4.1 Overview
      • 7.4.4.2 Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.5 Bladder Cancer Market
      • 7.4.5.1 Overview
      • 7.4.5.2 Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.6 Others Market
      • 7.4.6.1 Overview
      • 7.4.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 8.1 North America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
    • 8.1.1 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.1.2 North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
      • 8.1.2.1 North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.1.2.2 North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.1.3 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
    • 8.1.4 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.4.1 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.4.2 US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.1.4.2.1 US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.1.4.2.2 US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.1.5 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.5.1 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.5.2 Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.1.5.2.1 Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.1.5.2.2 Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.1.6 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.6.1 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.1.6.2 Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.1.6.2.1 Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.1.6.2.2 Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
    • 8.2.1 Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.2.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
      • 8.2.2.1 Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.2.2.2 Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.3 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
    • 8.2.4 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.4.1 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.4.2 UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.2.4.2.1 UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.4.2.2 UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.5 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.5.1 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.5.2 Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.2.5.2.1 Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.5.2.2 Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.6 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.6.1 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.6.2 France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.2.6.2.1 France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.6.2.2 France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.7 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.7.1 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.7.2 Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.2.7.2.1 Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.7.2.2 Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.2.8 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.8.1 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.2.8.2 Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.2.8.2.1 Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.2.8.2.2 Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027
    • 8.3.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.3.2 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
      • 8.3.2.1 Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.3.2.2 Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
    • 8.3.4 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.4.1 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.4.2 Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.3.4.2.1 Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.4.2.2 Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.5 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.5.1 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.5.2 China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.3.5.2.1 China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.5.2.2 China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.6 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.6.1 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.6.2 India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.3.6.2.1 India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.6.2.2 India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.7 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.7.1 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.7.2 South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.3.7.2.1 South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.7.2.2 South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.3.8 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.8.1 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.3.8.2 Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.3.8.2.1 Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.3.8.2.2 Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.4 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
    • 8.4.1 Middle East & Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.4.2 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
      • 8.4.2.1 Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.4.2.2 Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.4.3 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
    • 8.4.4 UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.4.1 UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.4.2 UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.4.4.2.1 UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.4.4.2.2 UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.4.4.3 Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.4.4 Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.4.5 Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.4.4.5.1 Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.4.4.5.2 Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.4.5 South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.5.1 South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4.5.2 South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.4.5.2.1 South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.4.5.2.2 South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 8.5 South And Central America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
    • 8.5.1 South and Central America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.5.2 South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
      • 8.5.2.1 South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.5.2.2 South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 8.5.3 South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
    • 8.5.4 Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5.4.1 Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5.4.2 Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.5.4.2.1 Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.5.4.2.2 Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 8.5.4.3 Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5.4.4 Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5.4.5 Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
        • 8.5.4.5.1 Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.5.4.5.2 Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9. Cancer Tissue Diagnostics Market- Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
    • 9.4.1 Product Launches
      • 9.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market
    • 9.4.2 Product Approvals
      • 9.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market
    • 9.4.3 Expansion & Other Activities
      • 9.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
    • 9.4.4 Product Enhancements
      • 9.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
  • 9.5 Inorganic Growth Strategies
    • 9.5.1 Overview
  • 9.6 Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
    • 9.6.1 Agreements
      • 9.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market
    • 9.6.2 Partnerships & Collaborations
      • 9.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
    • 9.6.3 Acquisitions
      • 9.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market

10. Cancer Tissue Diagnostics Market-Key Company Profiles

  • 10.1 Bio-Rad Laboratories, Inc.
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Financial Information
    • 10.1.4 Product Portfolio
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Thermo Fisher Scientific, Inc.
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Financial Information
    • 10.2.4 Product Portfolio
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 F. Hoffmann-La Roche Ltd.
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Abbott
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Enzo Biochem Inc.
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Agilent Technologies, Inc.
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Cancer Genetics Inc.
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Merck Kgaa (Sigma-Aldrich)
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Abcam Plc.
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Danaher
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Financial Information
    • 10.10.4 Product Portfolio
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary Of Terms

LIST OF TABLES

  • Table 1. North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 2. North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 3. North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 4. US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 5. US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 6. US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 7. Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 8. Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 9. Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 10. Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 11. Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 12. Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 13. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 14. Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 15. Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 16. UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 17. UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 18. UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 19. Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 20. Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 21. Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 22. France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 23. France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 24. France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 25. Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 26. Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 27. Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 28. Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 29. Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 30. Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 31. Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 32. Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 33. Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 34. Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 35. Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 36. Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 37. China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 38. China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 39. China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 40. India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 41. India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 42. India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 43. South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 44. South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 45. South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 46. Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 47. Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 48. Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 49. Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 50. Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 51. Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 52. UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 53. UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 54. UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 55. Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 56. Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 57. Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 58. South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 59. South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 60. South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 61. South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 62. South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 63. South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 64. Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 65. Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 66. Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 67. Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
  • Table 68. Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 69. Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 70. Recent Product Launches in the Cancer Tissue Diagnostics Market
  • Table 71. Recent product Approvals in the Cancer Tissue Diagnostics Market
  • Table 72. Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
  • Table 73. Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
  • Table 74. Recent Agreements By Players In The Cancer Tissue Diagnostics Market
  • Table 75. Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
  • Table 76. Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
  • Table 77. Glossary of Terms, Cancer Tissue Diagnostics Market

LIST OF FIGURES

  • Figure 1. Cancer Tissue Diagnostics Market Segmentation
  • Figure 2. Cancer Tissue Diagnostics Segmentation, by Region
  • Figure 3. Asia Pacific Cancer Tissue Diagnostics Market, Revenue (US$ Mn), By Geography 2018 & 2027
  • Figure 4. Global Cancer Tissue Diagnostics Market By Test Type, Market Share (%), 2018
  • Figure 5. North America : PEST Analysis
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Asia - Pacific: PEST Analysis
  • Figure 8. Middle East & Africa: PEST Analysis
  • Figure 9. South & Central America: PEST Analysis
  • Figure 10. Most Prevalent Forms of Cancers Globally, 2018
  • Figure 11. Cancer Tissue Diagnostics Market Impact Analysis of Driver and Restraints
  • Figure 12. Global Cancer Tissue Diagnostics Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 13. Global Cancer Tissue Diagnostics Market - by Geography Forecasts and Analysis - 2018- 2027
  • Figure 14. Prominent Players in the Cancer Tissue Diagnostics Market
  • Figure 15. Global Cancer Tissue Diagnostics Market, by Test Type 2018 & 2027 (%)
  • Figure 16. Global Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 17. Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 18. Global Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 19. Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 20. Global Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. Global In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 24. Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 26. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 27. North America Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 28. North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 30. US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 32. Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. Europe Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
  • Figure 34. Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 35. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
  • Figure 36. UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 37. Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 38. France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 40. Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. Asia Pacific Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
  • Figure 42. Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
  • Figure 44. Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 46. India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 48. Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 49. Middle East & Africa Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
  • Figure 50. Middle East & Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 51. Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
  • Figure 52. UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 53. Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 54. South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 55. South and Central America Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
  • Figure 56. South and Central America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 57. South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
  • Figure 58. Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 59. Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 60. Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019
  • Figure 61. Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
  • Figure 62. Inorganic Developments in the Cancer Tissue Diagnostics Market, 2016-2019(%)
Back to Top